Prehabilitation for EOC, Fallopian Tube, Primary Peritoneal Carcinoma and Pancreatic Cancer w/ NACT
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
Beijing Biotech
Daiichi Sankyo
Imunon
Blue Earth Diagnostics
AbbVie
Myeloid Therapeutics
Incyte Corporation
Fundacion Clinic per a la Recerca Biomédica
Case Comprehensive Cancer Center
Regeneron Pharmaceuticals
Memorial Sloan Kettering Cancer Center
AstraZeneca
TORL Biotherapeutics, LLC
Shanghai Gynecologic Oncology Group
Avenzo Therapeutics, Inc.
Institut Claudius Regaud
Radboud University Medical Center
AGO Research GmbH
UNC Lineberger Comprehensive Cancer Center
National Cancer Center, Korea
Nurix Therapeutics, Inc.
Sichuan Baili Pharmaceutical Co., Ltd.
Bicara Therapeutics
Massachusetts General Hospital
858 Therapeutics, Inc.
Context Therapeutics Inc.
Medicenna Therapeutics, Inc.
Memorial Sloan Kettering Cancer Center
Stanford University
Bio-Path Holdings, Inc.
Institut du Cancer de Montpellier - Val d'Aurelle
Ente Ospedaliero Ospedali Galliera
European Institute of Oncology
University of Pittsburgh
K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
Light Chain Bioscience - Novimmune SA
Hospices Civils de Lyon
Shantou University Medical College
Second Affiliated Hospital of Wenzhou Medical University
BioEclipse Therapeutics
Yonsei University
Sheba Medical Center
Karolinska University Hospital
Peking University Third Hospital
Groupe Hospitalier Diaconesses Croix Saint-Simon
Japanese Gynecologic Oncology Group